Chengchao Ding

University of Science and Technology of China

H指数:19

被引数:1,698

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Receptor binding domain-independent pancoronavirus vaccine design by fusion of conserved T/B Epitopes

通过融合保守的T/B表位进行受体结合域独立的泛冠状病毒疫苗设计

Emerging Microbes and Infections

IF7.5

2026-02-200

Persistent inflammatory markers existing with HIV-1 reservoirs in antiretroviral therapy treated HIV-1 individuals

抗逆转录病毒治疗下的HIV-1感染者中，持续存在的炎症标志物与HIV-1储库并存

Cytokine

IF3.7

2026-02-080

PRE

Study on the strengthening mechanism of carbon nanotube film interlayer assisted for brazing C/C composite and Nb

碳纳米管薄膜中间层辅助钎焊C/C复合材料与Nb的强化机制研究

Carbon

IF11.6

2025-07-160

PRE

Decreased CD4+ T cell counts drive aberrant B cell repertoire alterations in people living with HIV

CD4+ T细胞计数减少导致人类免疫缺陷病毒感染者B细胞受体库发生异常改变

Antiviral Research

IF4

2025-07-080

PRE

Impact of CD4+T cell and TCR repertoires on SARS-CoV-2-Specific antibody responses in PLWH following COVID-19 vaccination

JOURNAL OF IMMUNOLOGY

IF3.4

2025-04-010

PRE

Advances in Mechanism of HIV-1 Immune Reconstitution Failure: Understanding Lymphocyte Subpopulations and Interventions for Immunological Nonresponders

JOURNAL OF IMMUNOLOGY

IF3.4

2024-06-015

PRE

Are the original SARS-CoV-2 novel mutants from in vitro culture able to escape the immune response?

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2023-07-131

Two Resveratrol Oligomers Inhibit Cathepsin L Activity to Suppress SARS-CoV-2 Entry

两种白藜芦醇低聚物抑制组织蛋白酶L活性以抑制SARS-CoV-2进入

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

IF6.2

2023-03-308

Evaluation of humoral immune responses induced by different SARS-CoV-2 spike trimers from wild-type and emerging variants with individual, sequential, and combinational delivered strategies

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2022-08-297

Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-08-3010

OAAI

Crucial Mutations of Spike Protein on SARS-CoV-2 Evolved to Variant Strains Escaping Neutralization of Convalescent Plasmas and RBD-Specific Monoclonal Antibodies

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-08-1736

OAAI

Employing Broadly Neutralizing Antibodies as a Human Immunodeficiency Virus Prophylactic & Therapeutic Application

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-07-207

OAAI

A colorimetric immunoassay for determination of Escherichia coli O157:H7 based on oxidase-like activity of cobalt-based zeolitic imidazolate framework

MICROCHIMICA ACTA

IF5.3

2020-08-2113

PREAI

Characteristics of patients with coronavirus disease (COVID-19) confirmed using an IgM-IgG antibody test

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2020-05-07133

Advances in Developing CAR T-Cell Therapy for HIV Cure

FRONTIERS IN IMMUNOLOGY

IF5.9

2020-03-1063

OAAI

Attenuated Listeria monocytogenes as a Vaccine Vector for the Delivery of OMPW, the Outer Membrane Protein of Aeromonas hydrophila

FRONTIERS IN MICROBIOLOGY

IF4.5

2020-02-219

OAAI

Attenuated Listeria monocytogenes protecting zebrafish (Danio rerio) against Vibrio species challenge

MICROBIAL PATHOGENESIS

IF3.5

2019-07-0116

PREAI

Reactive oxygen species inhibit biofilm formation of Listeria monocytogenes

活性氧抑制单增李斯特菌生物膜形成

MICROBIAL PATHOGENESIS

IF3.5

2019-02-0125

PREAI

Exploration of the bacterial invasion capacity of Listeria monocytogenes in ZF4 cells

MICROBIAL PATHOGENESIS

IF3.5

2018-11-014

PREAI

Gut Microbiota and Relevant Metabolites Analysis in Alcohol Dependent Mice

FRONTIERS IN MICROBIOLOGY

IF4.5

2018-08-1555

OAAI

Chengchao Ding

个人简介

教育背景

工作经历

荣誉奖项

研究方向